Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
Preprint
- 22 July 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Complementing whole genome sequencing strategies with high-throughput multiplex RT-qPCR genotyping allows for more comprehensive and real-time tracking of SARS-CoV-2 variants of concern. During the second and third waves of COVID-19 in Qatar, PCR genotyping, combined with Sanger sequencing of un-typeable samples, was employed to describe the epidemiology of the Alpha, Beta and Delta variants. A total of 9792 nasopharyngeal PCR-positive samples collected between April-June 2021 were successfully genotyped, revealing the importation and transmission dynamics of these three variants in Qatar.Keywords
Other Versions
- Published version: Version International Journal of Infectious Diseases, 112, preprints
This publication has 12 references indexed in Scilit:
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in QatarNature Medicine, 2021
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 VariantsThe New England Journal of Medicine, 2021
- Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021Eurosurveillance, 2021
- SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individualsiScience, 2021
- Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, QatarEmerging Infectious Diseases, 2021
- SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyEClinicalMedicine, 2021
- A Novel Point Mutation in the N Gene of SARS-CoV-2 May Affect the Detection of the Virus by Reverse Transcription-Quantitative PCRJournal of Clinical Microbiology, 2021
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicScientific Reports, 2021
- Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern v3Published by ZappyLab, Inc. ,2021
- Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure settingPublished by Cold Spring Harbor Laboratory ,2020